Category: Longevity Research | Reading time: 5 min | For research use only
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide (MDP) encoded within the mitochondrial genome rather than the nuclear genome — a distinction that makes it structurally and biologically unique among the peptides currently studied in longevity and metabolic research. Identified in 2015 by Lee et al. at the University of Southern California, MOTS-C has become an emerging focus of research into mitochondrial signaling, metabolic regulation, and cellular stress response.
This article provides a research overview of MOTS-C for scientific and educational purposes. All compounds discussed are strictly for laboratory and research use only.
Molecular Profile
- Full name: Mitochondrial Open Reading Frame of the 12S rRNA-c
- Origin: Encoded in the 12S rRNA region of mitochondrial DNA (mtDNA)
- Sequence: Arg-Ala-Asp-Ala-Ala-Leu-Ser-Glu-Leu-Val-Gln-His-His-Leu-Arg-Ala-His-Thr-Gln (21 amino acids)
- Molecular weight: ~2,174 g/mol
- Form: Lyophilized powder (research grade)
- Stability: Store at −20°C; protect from repeated freeze-thaw cycles
MOTS-C's mitochondrial genomic origin is significant from a research perspective. Unlike nuclear-encoded peptides, its synthesis occurs within the mitochondria, and its translocation to the cytoplasm and nucleus has been documented as part of its signaling activity — a mechanism that has opened new research directions in mitochondria-to-nucleus communication.
Discovery and Background
Prior to the identification of MOTS-C, the mitochondrial genome was understood primarily in terms of its role encoding components of the oxidative phosphorylation machinery. The identification of small open reading frames within non-coding mitochondrial RNA regions — including the 12S ribosomal RNA — expanded the understanding of mitochondrial biology considerably.
MOTS-C was identified using bioinformatic screening of conserved open reading frames within the 12S rRNA region, followed by mass spectrometry confirmation of the peptide in human plasma and tissue samples. Its detection in circulation suggested an endocrine-like signaling role beyond the mitochondria of origin, which has been a central hypothesis driving subsequent research.
Mechanisms Studied in Preclinical Research
AMPK pathway activation The most extensively studied mechanism associated with MOTS-C involves AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. Research has documented MOTS-C-associated AMPK phosphorylation in skeletal muscle and hepatic cell models, with investigators examining downstream effects on fatty acid oxidation, glucose uptake, and mitochondrial biogenesis markers.
Folate-methionine cycle interaction The original Lee et al. (2015) publication identified MOTS-C's interaction with the folate cycle and methionine metabolism as a mechanistic element linking mitochondrial status to nuclear gene expression. Specifically, MOTS-C was found to inhibit the folate cycle in a manner that reduces AICAR production — an endogenous AMPK activator — providing a proposed mechanism for its metabolic effects.
Nuclear translocation and gene regulation Research has documented MOTS-C translocation from the mitochondrial compartment to the nucleus under cellular stress conditions. Studies have examined whether nuclear MOTS-C interacts with stress-response transcription factors, potentially linking mitochondrial function directly to nuclear gene expression programs — a concept referred to as mitochondrial-nuclear retrograde signaling.
Insulin sensitivity models Rodent studies examining MOTS-C in models of diet-induced insulin resistance have reported associations with improved glucose tolerance and insulin sensitivity parameters, positioning MOTS-C within the broader research landscape of metabolic syndrome models.
Skeletal muscle research Given AMPK's role in skeletal muscle energy metabolism, research has examined MOTS-C in muscle cell models examining mitochondrial content, oxidative capacity markers, and exercise adaptation parameters in animal models. Studies comparing sedentary and exercised rodents have noted differences in circulating MOTS-C levels, motivating research into whether MOTS-C functions as an exercise-induced mitokine.
MOTS-C as a Mitokine
A significant conceptual development in MOTS-C research is its classification as a potential "mitokine" — a mitochondria-derived peptide that circulates systemically and exerts effects in tissues distant from its site of synthesis. Research has measured MOTS-C concentrations in human plasma, noting associations with age, metabolic status, and physical fitness in observational studies.
Published human data includes:
- Plasma MOTS-C levels have been reported to decline with age in cross-sectional human studies
- Associations between MOTS-C concentrations and insulin sensitivity markers have been reported in clinical cohort studies
- Exercise training has been associated with altered MOTS-C plasma levels in intervention studies
These observational findings motivate the ongoing preclinical mechanistic research using exogenous MOTS-C administration in animal models.
Areas of Active Research
Aging and longevity models The association between declining MOTS-C levels and aging has made it a subject of interest in geroscience research. Long-lived animal models and caloric restriction studies have examined whether MOTS-C mediates some of the metabolic benefits observed in lifespan-extension paradigms.
Exercise biology The potential role of MOTS-C as an exercise-responsive mitokine has generated research interest in exercise physiology, with studies examining whether exogenous MOTS-C administration recapitulates aspects of exercise-induced metabolic adaptation in sedentary animal models.
Inflammatory models Research has examined MOTS-C in inflammatory contexts, noting associations with modulation of NF-κB signaling in treated cell cultures. Investigators have proposed connections between mitochondrial stress signaling, MOTS-C secretion, and innate immune regulation.
Bone and joint research More recent publications have examined MOTS-C in osteoblast and chondrocyte models, investigating whether mitochondrial-derived signaling affects bone formation and cartilage metabolism parameters.
Key Published Research
- Lee C, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443–454.
- Reynolds JC, et al. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12, 470.
- Lu H, et al. (2019). MOTS-c: A novel exercise-induced mitochondrial-derived peptide regulating physical capacity and aging. Frontiers in Physiology, 10, 1089.
- Zempo H, et al. (2021). A sex-dependent mitochondrial stress signaling pathway underlies the effects of MOTS-c on aging. Nature Communications, 12, 4237.
Research Considerations
MOTS-C represents a relatively recently identified peptide, and its research profile — while growing rapidly — remains less extensive than compounds like BPC-157 or TB-500 with decades of published literature. Researchers should approach the current literature as an evolving picture rather than an established consensus.
The distinction between endogenous MOTS-C (produced intracellularly from mitochondrial ribosomes) and exogenously administered synthetic MOTS-C (the research compound) is an important consideration when designing experiments and interpreting outcomes. Cellular uptake mechanisms and bioavailability of exogenous MOTS-C are active research questions.
NordBioLab supplies MOTS-C as a research-grade lyophilized peptide with ≥98% purity (HPLC verified) and full COA documentation per batch.
All products and information provided by NordBioLab are strictly for scientific research and laboratory use only. Not for human or veterinary consumption. This article does not constitute medical advice.